Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia

The Journal of Clinical Investigation
A F StalenhoefR J Havel

Abstract

The metabolism of apolipoproteins B-48 and B-100 (apo B-48 and B-100) in large triglyceride-rich lipoproteins was studied in three adults with familial dysbetalipoproteinemia (F. dys.) and compared to that of normolipidemic subjects. One Caucasian F. dys. subject was apparently homozygous for the common form of apo E-2, (Arg158----Cys), whereas the two Black subjects were homozygous for a different apo E-2 mutant (Arg145----Cys), which displays much less defective binding to cells than apo E-2 (Arg158----Cys). The lipoproteins were labeled with 125I and injected intravenously into fasted recipients. The results indicate that the terminal catabolism of triglyceride-rich lipoproteins of intestinal and hepatic origin is markedly impaired in apo E2/2 homozygotes with alleles Arg158----Cys and Arg145----Cys; despite long residence times, apo B-48 of chylomicrons and apo B-100 of large very low density lipoproteins are not converted appreciably to intermediate or low density lipoproteins in apo E2/2 homozygotes.

References

Feb 1, 1975·Annals of Internal Medicine·J MorganrothD S Fredrickson
Nov 1, 1979·Metabolism: Clinical and Experimental·A P GoldbergW R Hazzard
Jul 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R J Havel, J P Kane
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S C RallR W Mahley
Jan 1, 1983·Annual Review of Physiology·J P Kane
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A F StalenhoefR J Havel
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·C EhnholmJ L Witztum
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J P KaneR J Havel
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J P KaneH E Paulus
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R J HavelL S Guo
Nov 1, 1982·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R J HavelM S Brown
May 1, 1982·Metabolism: Clinical and Experimental·M F ReardonG Steiner
Jul 20, 1982·Biochimica Et Biophysica Acta·D B ZilversmitK H Thompson
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Jan 1, 1988·Journal of Inherited Metabolic Disease·A M Salter, D N Brindley
Jan 25, 2013·Current Atherosclerosis Reports·D C ChanG F Watts
Apr 1, 1988·Clinical Biochemistry·M HuettingerH Goldenberg
Jul 1, 1997·The Proceedings of the Nutrition Society·R J Havel
Jun 30, 1998·Current Opinion in Lipidology·J de Graaf, A F Stalenhoef
Feb 11, 1999·Australian and New Zealand Journal of Medicine·G F WattsT G Redgrave
Aug 1, 1987·The Journal of Clinical Investigation·Y A KesäniemiT A Miettinen
Sep 1, 1994·The Journal of Clinical Investigation·P de KnijffL M Havekes
Sep 11, 2012·The Journal of Clinical Endocrinology and Metabolism·Lars BerglundUNKNOWN Endocrine society
Feb 1, 1987·American Heart Journal·R J HavelD M Shames
Sep 1, 1991·Scandinavian Journal of Clinical and Laboratory Investigation·P M StuytA van 't Laar
Mar 27, 2016·Journal of Lipid Research·Godfrey S Getz, Catherine A Reardon
Jan 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·K H WeisgraberR W Mahley
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Aug 27, 2005·Circulation Research·Jianguo LiVsevolod Y Polotsky
Jul 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J DallongevilleS Lussier-Cacan
Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J DallongevilleS Lussier-Cacan
Jun 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M C CabezasD W Erkelens
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·F K WeltyE J Schaefer
Nov 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R J Havel, R L Hamilton
Oct 1, 1989·European Journal of Clinical Investigation·S M HaffnerW R Hazzard
Jun 11, 1998·Journal of Applied Physiology·A E HardmanS L Herd
Nov 4, 2006·Journal of Applied Physiology·Jianguo LiVsevolod Y Polotsky
Jul 1, 1987·The American Journal of Physiology·R J Havel

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.